Americans are paying more and getting less for their health care than ever before. On the new season of Prognosis, reporter John Tozzi explores what went wrong. 

Americans are paying more and getting less for their health care than ever before. On the new season of Prognosis, reporter John Tozzi explores what went wrong.

Money goes where it’s treated best. That simple truth is a big reason why more and more money (trillions, in fact) flows into a powerful, low-cost tool that’s quietly transformed investing. Exchange-traded funds let you invest in everything from the stock market to gold like never before. This biweekly podcast will demystify them—and hopefully delight you in the process.

Money goes where it&rsquo;s treated best. That simple truth is a big reason why more and more money (trillions, in fact) flows into a powerful, low-cost tool that&rsquo;s quietly transformed investing. Exchange-traded funds let you invest in everything from the stock market to gold like never before. This biweekly podcast will demystify them&mdash;and hopefully delight you in the process.

Joel Weber and Eric Balchunas demystify the world of exchange-traded funds, or ETFs.

Trillions

Introducing Prognosis Season 4: America's Broken Health-Care Costs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a5f558c9-5dfa-4159-81cd-ae3c002cea63/transcript

What if you invested at literally the worst possible moments in market history? According to Ben Carlson, the co-host of the Animal Spirits podcast and an advisor at Ritholtz Wealth Management, even the world's worst market timer could still become a millionaire. Carlson's new book, Risk & Reward, explores why long-term investing remains so psychologically difficult.

On this episode of Trillions, Eric Balchunas and Joel Weber speak with Carlson about his new book, which implores you to stop panicking and just stay the course. They discuss the genius of boring index funds, "fun accounts" as a behavioral release valve, whether buffer ETFs are financial Xanax and how the ETF wrapper may help turn tax efficiency into the new alpha. They also drill into Carlson's other big launch: Goaltender (GTND), a new ETF from Ritholtz, and go over why wealth managers are becoming ETF issuers.

What if you invested at literally the worst possible moments in market history? According to Ben Carlson, the co-host of the Animal Spirits podcast and an advisor at Ritholtz Wealth Management, even the world's worst market timer could still become a millionaire. Carlson's new book, Risk &amp; Reward, explores why long-term investing remains so psychologically difficult.
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Carlson about his new book, which implores you to stop panicking and just stay the course. They discuss the genius of boring index funds, "fun accounts" as a behavioral release valve, whether buffer ETFs are financial Xanax and how the ETF wrapper may help turn tax efficiency into the new alpha. They also drill into Carlson's other big launch: Goaltender (GTND), a new ETF from Ritholtz, and go over why wealth managers are becoming ETF issuers.

The Big Long: Risk and Reward With Ben Carlson

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9f06c129-4739-4d3f-bc59-b45001368216/transcript

A long-dormant trade is suddenly showing signs of life. Prices are climbing. Volumes are spiking. And in a corner of the market that’s spent years in the doldrums, one ETF is catching a fresh buzz — thanks in part to the US Justice Department’s move in April to reclassify medical marijuana as a less dangerous drug.

On this episode of Trillions, Eric Balchunas and Joel Weber debut a new monthly segment spotlighting an ETF that’s having a moment. This time, Bloomberg Intelligence’s Andre Yapp joins to break down the AdvisorShares Pure US Cannabis ETF (MSOS). The only cannabis-focused ETF with more than $1 billion in assets, it uses swaps to access marijuana companies just as shifting tax rules begin to ease the industry’s burden. The setup looks promising—but is this a real turning point, or just another short-lived high?

A long-dormant trade is suddenly showing signs of life. Prices are climbing. Volumes are spiking. And in a corner of the market that&rsquo;s spent years in the doldrums, one ETF is catching a fresh buzz &mdash; thanks in part to the US Justice Department&rsquo;s move in April to reclassify medical marijuana as a less dangerous drug.
On this episode of Trillions, Eric Balchunas and Joel Weber debut a new monthly segment spotlighting an ETF that&rsquo;s having a moment. This time, Bloomberg Intelligence&rsquo;s Andre Yapp joins to break down the AdvisorShares Pure US Cannabis ETF (MSOS). The only cannabis-focused ETF with more than $1 billion in assets, it uses swaps to access marijuana companies just as shifting tax rules begin to ease the industry&rsquo;s burden. The setup looks promising&mdash;but is this a real turning point, or just another short-lived high?

ETF of the Moment: A Budding Comeback for Cannabis

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/315bff9d-ecfd-489a-a7cd-b4490147b486/transcript

Markets hate uncertainty — unless, it turns out, they don’t. Under US President Donald Trump, investors have endured tariff scares, geopolitical flare-ups and a steady drumbeat of headline-driven panic. Yet stocks keep climbing; April, in particular, was a blockbuster. Maybe the best way to understand this market is to stop trying to make sense of it.

On this episode of Trillions, Eric Balchunas and Joel Weber speak with Bloomberg Intelligence’s Athanasios Psarofagis about what ETF data actually says about investing during a Trump presidency. His grab bag of stats — March is cursed, Thursdays are rough and some of the biggest gains happen while you sleep — paints a picture of a market behaving very differently under pressure. Together, they unpack why it feels more volatile than ever and explore why the investors who come out ahead are often the ones who do the least.

Markets hate uncertainty &mdash; unless, it turns out, they don&rsquo;t. Under US President Donald Trump, investors have endured tariff scares, geopolitical flare-ups and a steady drumbeat of headline-driven panic. Yet stocks keep climbing; April, in particular, was a blockbuster. Maybe the best way to understand this market is to stop trying to make sense of it.
On this episode of Trillions, Eric Balchunas and Joel Weber speak with Bloomberg Intelligence&rsquo;s Athanasios Psarofagis about what ETF data actually says about investing during a Trump presidency. His grab bag of stats &mdash; March is cursed, Thursdays are rough and some of the biggest gains happen while you sleep &mdash; paints a picture of a market behaving very differently under pressure. Together, they unpack why it feels more volatile than ever and explore why the investors who come out ahead are often the ones who do the least.

 How to Invest During a Trump Presidency

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6957e592-9578-4706-ac77-b4420138e5d5/transcript

Introducing Prognosis Season 4: America's Broken Health-Care Costs

In 1 playlist(s)

Trillions

Social links

Follow podcast

Recent clips